WASHINGTON — Before she boards her fifth flight of the week, the flight attendant completes a safety briefing, checks the exits, and confirms the galley is stocked. What she cannot check is her accumulated radiation dose. The United States does not require airlines to monitor it.
A study published Monday in JAMA Internal Medicine suggests that oversight gap is more consequential than regulators have acknowledged. Analyzing more than 12.7 million death certificates filed between 2020 and 2024, spanning 503 occupations, researchers at Harvard Medical School found that flight attendants had the highest proportional rate of radiation-related cancer deaths of any profession in the United States. Pilots ranked second. Both groups outpaced nuclear medicine technologists, workers in a field built specifically around radiation exposure, in their share of radiation-linked cancer fatalities.
The research, led by Vishal Patel of Harvard Medical School, is the largest occupational mortality analysis of its kind attempted in the United States. “Prior studies have generally been cohort studies assembled one airline, one country, or one cancer site at a time,” Patel told Gizmodo. This study’s population-scale dataset allowed for a comparison across the full occupational landscape, and the results placed aviation workers at the top of a list most would expect to be dominated by medical or industrial workers.
Approximately 14,000 pilots and 7,000 flight attendants were included in the study population. Among flight attendants, 6.9 percent of deaths were attributable to radiation-related cancers, roughly 50 percent higher than the median across all 503 professions studied. Pilots followed at 6.7 percent, a 36 percent elevation above the median. The cancer types driving both figures include breast, thyroid, prostate, multiple myeloma, leukemia, and melanoma.
One detail in the methodology provides a check against alternative explanations. Both pilots and flight attendants showed near-median rates for cancers with no established link to radiation exposure. That alignment is not what you would find if the elevated cancer burden reflected lifestyle patterns, healthcare access disparities, or demographic composition. It points specifically to occupational radiation as the operative variable.
The source of that radiation is not airport security imaging or onboard electronics. Flight crew flying long-haul international routes accumulate between three and six millisieverts of cosmic radiation annually, based on established altitude and route modeling. A leisure traveler taking ten round trips a year receives roughly 0.4 millisieverts over the same period. The difference in source matters for the policy question. “Shielding is the intuitive answer and it’s the wrong one,” Patel said. “At altitude you’re dealing with high-energy galactic cosmic rays.” These particles originate outside the solar system and penetrate the thin upper atmosphere without meaningful attenuation. Lead-lined cockpits are not an engineering solution.
What the study argues instead is that the problem is one of monitoring and attribution. European Union aviation regulators have required individual dosimetry tracking for flight crew since 2013, records that follow a worker across airlines and across borders throughout a career. The United States has no equivalent requirement. In a year when federal agencies have come under pressure to close FDA food safety disclosure gaps that persisted for decades, the absence of aviation dosimetry standards stands as a comparable regulatory blind spot.
A flight attendant who works for three carriers over a twenty-year career has no unified record of her cumulative radiation exposure. If she develops breast cancer at 52, that occupational history is invisible to her oncologist and to the epidemiologists working to understand why she got sick.
“A reasonable first step would be individual dose estimation with records that follow a crew member across employers over a career,” Patel said.
The study is not the first to flag elevated cancer rates among aviation workers. Research from Scandinavia, the United Kingdom, and individual American carriers has pointed in the same direction for more than two decades. The difference here is scale and comparative context. Placing aviation workers on a national occupational mortality map spanning 503 professions, and finding them at the top ahead of nuclear medicine technologists who handle radioactive isotopes by hand, is a result that is difficult to set aside.
The practical policy response remains undetermined. No federal framework currently exists for mandatory crew dosimetry, and the FAA has not signaled regulatory intent in this area. Airlines have defended existing voluntary exposure models on the grounds that average doses are low and current estimates adequately capture risk. Patel’s mortality data complicates that position without resolving it.
What the study leaves open is whether the dosimetry gap has produced a systematic undercount of occupational cancer across a workforce of hundreds of thousands. That question does not resolve here. It begins here.
Related Posts
